Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $4.34 billion. The enterprise value is $3.73 billion.
| Market Cap | 4.34B |
| Enterprise Value | 3.73B |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 217.94 million shares outstanding. The number of shares has increased by 14.28% in one year.
| Current Share Class | 217.94M |
| Shares Outstanding | 217.94M |
| Shares Change (YoY) | +14.28% |
| Shares Change (QoQ) | +3.72% |
| Owned by Insiders (%) | 1.72% |
| Owned by Institutions (%) | 54.14% |
| Float | 154.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 406.44 |
| Forward PS | 413.38 |
| PB Ratio | 5.87 |
| P/TBV Ratio | 6.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 349.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.13, with a Debt / Equity ratio of 0.05.
| Current Ratio | 22.13 |
| Quick Ratio | 21.58 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -40.01% and return on invested capital (ROIC) is -25.70%.
| Return on Equity (ROE) | -40.01% |
| Return on Assets (ROA) | -24.72% |
| Return on Invested Capital (ROIC) | -25.70% |
| Return on Capital Employed (ROCE) | -44.26% |
| Weighted Average Cost of Capital (WACC) | 13.40% |
| Revenue Per Employee | $55,316 |
| Profits Per Employee | -$1.41M |
| Employee Count | 193 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +446.98% in the last 52 weeks. The beta is 1.68, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +446.98% |
| 50-Day Moving Average | 15.76 |
| 200-Day Moving Average | 10.70 |
| Relative Strength Index (RSI) | 62.54 |
| Average Volume (20 Days) | 4,583,949 |
Short Selling Information
The latest short interest is 43.04 million, so 19.75% of the outstanding shares have been sold short.
| Short Interest | 43.04M |
| Short Previous Month | 38.12M |
| Short % of Shares Out | 19.75% |
| Short % of Float | 27.79% |
| Short Ratio (days to cover) | 8.72 |
Income Statement
In the last 12 months, RLAY had revenue of $10.68 million and -$272.71 million in losses. Loss per share was -$1.57.
| Revenue | 10.68M |
| Gross Profit | -245.58M |
| Operating Income | -296.46M |
| Pretax Income | -272.71M |
| Net Income | -272.71M |
| EBITDA | -293.61M |
| EBIT | -296.46M |
| Loss Per Share | -$1.57 |
Balance Sheet
The company has $642.07 million in cash and $31.57 million in debt, with a net cash position of $610.50 million or $2.80 per share.
| Cash & Cash Equivalents | 642.07M |
| Total Debt | 31.57M |
| Net Cash | 610.50M |
| Net Cash Per Share | $2.80 |
| Equity (Book Value) | 642.18M |
| Book Value Per Share | 3.39 |
| Working Capital | 628.71M |
Cash Flow
In the last 12 months, operating cash flow was -$213.36 million and capital expenditures -$26,000, giving a free cash flow of -$213.38 million.
| Operating Cash Flow | -213.36M |
| Capital Expenditures | -26,000 |
| Depreciation & Amortization | 2.85M |
| Net Borrowing | n/a |
| Free Cash Flow | -213.38M |
| FCF Per Share | -$0.98 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,776.87% |
| Pretax Margin | -2,554.37% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.28% |
| Shareholder Yield | -14.28% |
| Earnings Yield | -6.28% |
| FCF Yield | -4.92% |
Analyst Forecast
The average price target for RLAY is $25.08, which is 25.97% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.08 |
| Price Target Difference | 25.97% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 29.89% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RLAY has an Altman Z-Score of 5.86 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.86 |
| Piotroski F-Score | 4 |